Life Sciences Talks: From the lab to the market

Portolano Cavallo is thrilled to host an upcoming seminar as part of the “Life Sciences Talks” series by the Italian Tech Alliance. This event is organized in collaboration with Human Technopole and Wilson Sonsini.

The seminar will highlight the critical role of robust IP strategies, both domestically and globally, in attracting capital and planning effective US expansion.

The discussion will feature concrete experiences and insights on IP challenges faced by two Italian biotech companies: Alia Therapeutics, which is developing novel CRISPR systems for gene therapy applications, and CheckmAb, which is creating monoclonal antibody-based immunotherapy specifically targeting intra-tumoral regulatory T cells.

Topics will include:

• Exploring patentability, licensing, and commercialization dynamics in highly competitive innovation spaces, and how to establish your own edge and freedom to operate (FTO)
• Navigating the global landscape, how to protect and promote your innovation across different regions: understanding key differences in patent law interpretations by region (e.g., US, EU, China)
• Leveraging the complementarity of patent protection and trade secrets
• Adapting patent filing strategies for financial investments and strategic partnerships

Speakers:

• Francesco Cerruti – General Director, Italian Tech Alliance
• Fabio Terragni – Member of the Management Committee delegate for Technology Transfer, CITT, Human Technopole
• Gianmario Verona – President, Human Technopole
• Dr. Lou Lieto – Chair, Patent & Innovation Department; Partner Wilson Sonsini
• Maria Balestriero – Of Counsel, Portolano Cavallo
• Letizia Goretti – CEO and Member of the Board, Alia Therapeutics
• Renata Maria Grifantini – CSO and General Director, CheckmAb

Luca Gambini (Partner, Portolano Cavallo) will moderate the panel.

The seminar will be held in English.

Due to limited availability of seats, please register for the event by filling the application form below. You will receive a confirmation email in the next few days.